Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Isoproterenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 9/20 | 0.85 |
| ▸ | ADRB1 known ✓ | P08588 | 6/20 | 0.85 |
| ▸ | ADRB3 known ✓ | P13945 | 6/20 | 0.85 |
| ▸ | MAPT | P10636 | 8/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.85 |
| ▸ | MEN1 | O00255 | 6/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.85 |
| ▸ | LMNA | P02545 | 6/20 | 0.85 |
| ▸ | TSHR | P16473 | 4/20 | 0.85 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.85 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.85 |
| ▸ | MTOR | P42345 | 3/20 | 0.85 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.85 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.85 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.85 |
| ▸ | DRD2 | P14416 | 2/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoproterenol SCHEMBL582812 | 0.98 | ADRB2 (0.85) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Isoproterenol SCHEMBL41841 | 0.97 | MAPT (0.85) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Isoproterenol SCHEMBL5682034 | 0.95 | MAPT (0.82) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Isoproterenol SCHEMBL29519146 | 0.92 | MAPT (1.00) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Isoproterenol SCHEMBL3253794 | 0.92 | MAPT (1.00) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Isoproterenol SCHEMBL29386243 | 0.92 | MAPT (1.00) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Levisoprenaline SCHEMBL29620666 | 0.92 | MAPT (1.00) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Isoproterenol SCHEMBL4165 | 0.92 | MAPT (1.00) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Isoproterenol SCHEMBL4166 | 0.92 | MAPT (1.00) | ADRB2MAPTKDM4ETDP1ADRB1 | |
| Levisoprenaline SCHEMBL250806 | 0.92 | MAPT (1.00) | ADRB2MAPTKDM4ETDP1ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110753541-A | Pharmaceutical compositions for in vivo delivery, process for preparing substantially water insoluble pharmacologically active agents | ZY治疗公司 | 2020-02-04 | — | — | CN | disclosed |
| WO-2003084470-A2 | COMPOSITIONS AND METHODS FOR TARGETED BIOLOGICAL DELIVERY OF MOLECULAR CARRIERS | ARIZEKE PHARMACEUTICALS, INC. (US) | 2003-10-16 | — | — | WO | disclosed |